✦ LIBER ✦

Therapeutic options in nonalcoholic fatty liver disease

✍ Scribed by Jeffrey L. Tokar; Carl L. Berg

Book ID: 107556252
Publisher: Springer
Year: 2002
Tongue: English
Weight: 474 KB
Volume: 5
Category: Article
ISSN: 1092-8472
DOI: 10.1007/s11938-002-0030-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hypouricemic therapy: A novel potential

Hypouricemic therapy: A novel potential therapeutic option for nonalcoholic fatty liver disease

✍ Cheng-Fu Xu; Chao-Hui Yu; Lei Xu; Xiao-Ying Sa; You-Ming Li 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB 👁 1 views

We read with great interest the practice guidelines for the diagnosis and management of autoimmune hepatitis recently issued by the American Association for the Study of Liver Diseases (AASLD). 1 In particular, we appreciate the new definition of biochemical remission, which now requires not only no

Nonalcoholic fatty liver disease

✍ Zobair M. Younossi 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 217 KB

Therapeutic potential of green tea in no

Therapeutic potential of green tea in nonalcoholic fatty liver disease

✍ Christopher Masterjohn; Richard S Bruno 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB

Nonalcoholic fatty liver disease after l

Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease

✍ Kanthi Yalamanchili; Sherif Saadeh; Göran B. Klintmalm; Linda W. Jennings; Gary 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

Nonalcoholic steatohepatitis (NASH) may account for many cases of cryptogenic cirrhosis. If so, then steatosis might recur after liver transplantation. Two thousand fifty-two patients underwent primary liver transplantation for chronic liver disease between 1986 and 2004. Serial liver biopsy samples

Nonalcoholic fatty liver disease and liv

Nonalcoholic fatty liver disease and liver transplantation

✍ Paul Angulo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Nonalcoholic fatty liver disease affects a substantial proportion of the general population worldwide. This high prevalence of nonalcoholic fatty liver disease has important consequences in the donor selection process for liver transplantation, and in the posttransplant period given the high recurre

Adipocytokine levels in nonalcoholic fat

Adipocytokine levels in nonalcoholic fatty liver disease

✍ Teoman Dogru; Cemal Nuri Ercin; Serkan Tapan; Murat Kantarcioglu; Muammer Kara; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

Li et al. have analyzed golgi phosphoprotein 2 (GOLPH2) serum levels in a cohort of patients with liver cirrhosis, healthy controls, and patients with hepatocellular carcinoma (HCC). They found elevated serum levels of GOLPH2 (sGOLPH2) in early HCC cases. From their findings, the authors conclude th